PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot
Not Applicable
Terminated
- Conditions
- Diabetic FootOsteoarthritis
- Interventions
- Procedure: Bone scintigraphyProcedure: LeukoscanProcedure: PET / CTProcedure: Bone biopsyBiological: Bloodwork
- Registration Number
- NCT01322256
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
The investigators' primary objective is to assess the predictive power of PET/CT scanning in the evolution of infectious osteoarthritis of the diabetic diabetic after antibiotic therapy prescribed by national and international recommendations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- Patient has type I or type II diabetes
- Patient consulting in the department of Metabolic and Endocrine Diseases (Caremeau Hospital) or the department of Nutritional Diseases and Diabetology (Grau de Roi Medical Center) at the Nîmes University Hospital
- Patient has infected osteoarthritis of the foot according to the International Working Group on the Diabetic Foot with a probability > 50% (score >= 2).
Exclusion Criteria
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient is pregnant
- The patient is breastfeeding
- Patient has severe sepsis or a stage 4 infection according to the international consensus on the diabetic foot
- Patient has severe renal insufficiency as defined by glomerular filtration rate < 30ml/min/1.73 m^2, calculated according to the MDRD equation, and is not undergoing dialysis
- Patient has a contra-indication for an MRI
- pacemaker
- intracranial clips
- metallic inclusions
- severe claustrophobia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Included patients Bone scintigraphy Patients included in the study according to stated inclusion and exclusion criteria Intervention: Bone scintigraphy Intervention: Leukoscan Intervention: PET / CT Intervention: Bone biopsy Intervention: Bloodwork Included patients Bone biopsy Patients included in the study according to stated inclusion and exclusion criteria Intervention: Bone scintigraphy Intervention: Leukoscan Intervention: PET / CT Intervention: Bone biopsy Intervention: Bloodwork Included patients Leukoscan Patients included in the study according to stated inclusion and exclusion criteria Intervention: Bone scintigraphy Intervention: Leukoscan Intervention: PET / CT Intervention: Bone biopsy Intervention: Bloodwork Included patients PET / CT Patients included in the study according to stated inclusion and exclusion criteria Intervention: Bone scintigraphy Intervention: Leukoscan Intervention: PET / CT Intervention: Bone biopsy Intervention: Bloodwork Included patients Bloodwork Patients included in the study according to stated inclusion and exclusion criteria Intervention: Bone scintigraphy Intervention: Leukoscan Intervention: PET / CT Intervention: Bone biopsy Intervention: Bloodwork
- Primary Outcome Measures
Name Time Method The difference between AUCs for PET/CT scan and scintigraphy 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Centre Hospitalier Universitaire de Nîmes
🇫🇷Nîmes Cedex 09, Gard, France
CHU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi
🇫🇷Le Grau du Roi, France